CIK 0001984086 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 46.0 M | 151000 |
| Net income (USD) | -48.9 M | 4.2 M |
| Diluted EPS (USD/shares) | -1.1 | 0.29 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-19 | 4 | 4 | 2026-10-15 |
| 2026-10-01 | 144 | 144 | |
| 2026-10-01 | 144 | 144 | |
| 2026-09-10 | 4 | 4 | 2026-09-08 |
| 2026-09-03 | 3 | 3 | 2026-08-24 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-08-25 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-08-22 |
| 2026-08-14 | 4 | 4 | 2026-08-12 |
| 2026-08-14 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-08-14 | 4 | 4 | 2026-08-12 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | 4 | 4 | 2026-08-11 |
| 2026-08-12 | 144 | 144 | |
| 2026-08-12 | 144 | 144 | |
| 2026-08-12 | 144 | 144 | |
| 2026-08-11 | 144 | 144 | |
| 2026-08-10 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-10 | 8-K | 8-K items 2.02,9.01 | 2026-08-10 |
| 2026-08-05 | 4 | 4 | 2026-08-03 |
| 2026-07-17 | 4 | 4 | 2026-07-15 |
| 2026-07-15 | 144 | 144 | |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-06-30 | 4 | 4 | 2026-06-26 |
| 2026-06-30 | 4 | 4 | 2026-06-29 |
| 2026-06-30 | 4 | 4 | 2026-06-26 |
Forms on file (last 1,000): 4 61, 8-K 26, 3 19, 144 15, SCHEDULE 13G/A 6, 10-Q 6, CORRESP 4, S-8 3. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SEPN (0.002 USD), /gw/filings/filings?ticker=SEPN&form=8-K, /gw/filings/facts?ticker=SEPN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange